Nexscient, Inc. 8-K

What Happened

• Nexscient, Inc. filed an 8‑K reporting that Chief Operating Officer Tarek Shoufani resigned as COO effective June 30, 2026; he will remain a non‑employee member of the board.
• The board unanimously appointed Jaime Fanlo as a director effective July 1, 2026. The board determined Mr. Fanlo is an independent director under Nasdaq rules. Mr. Fanlo is an experienced corporate lawyer, investor, and currently a stockholder; his background includes roles at Johnson Controls, CBRE, and involvement in Nexscient’s acquisition/integration of Flipside AI.
• Nexscient entered into Director Agreements (effective July 1, 2026) with Tarek Shoufani, Eric Manlunas, and Jaime Fanlo, granting each a performance‑based restricted stock unit (RSU) award of 250,000 units (each unit convertible to one share upon vesting).

Key Details

• COO resignation: Tarek Shoufani resigned as COO effective June 30, 2026; not due to any disagreement with the company.
• Director appointment: Jaime Fanlo appointed effective July 1, 2026; qualifies as an independent director.
• RSU awards: 250,000 RSUs granted to each of three non‑employee directors (total possible 750,000 shares); grants made as standalone inducement awards (not under an equity plan).
• Vesting and term: RSUs vest only upon achievement of specified market‑capitalization thresholds sustained for 20 consecutive trading days, subject to continuous service; performance period is 10 years from grant; unachieved units are forfeited. No cash retainer or meeting fees—directors receive only RSU awards, expense reimbursement, and indemnification.

Why It Matters

• Leadership & governance: The COO move to a non‑employee director role preserves Shoufani’s board involvement while changing day‑to‑day management structure; new independent director adds governance experience and cross‑border transaction expertise.
• Shareholder impact: The RSU awards align directors’ pay with company market‑cap performance but could result in issuance of up to 750,000 new shares if all awards vest, which investors should monitor for potential dilution.
• Investor takeaway: This 8‑K focuses on leadership changes and long‑dated, market‑performance equity awards to directors—important for understanding board composition, director incentives, and possible future changes in share count.